Pyoderma due to resistant Staphylococcus aureus following topical application of neomycin.
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D002175:Candida / Q000302:isolation & purification; D002177:Candidiasis / Q000209:etiology; D004352:Drug Resistance, Microbial; D006801:Humans; D008297:Male; D009355:Neomycin / Q000008:administration & dosage / Q000009:adverse effects*; D009779:Occlusive Dressings; D011711:Pyoderma / Q000209:etiology*; D013203:Staphylococcal Infections / Q000209:etiology*; D013210:Staphylococcus / Q000187:drug effects / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D009355:Neomycin